The selection of ECG leads used for ST monitoring may influence detection and quantitation of ischaemia.
Introduction
Patients with unstable angina may suffer from early unfavourable cardiac events in spite of intensive medical therapy. Prognosis is defined primarily by the recurrence and severity of silent or symptomatic myocardial ischaemia and by the presence of multivessel coronary artery disease' 1 " 7 ' . The assessment of the total ischaemic burden and the identification of patients at risk should preferably be based on continuous ECG monitoring techniques. Continuous ST monitoring, whether on-line or by Holter recording with subsequent off-line analysis, has been limited by a restricted number of 2 or 3 ECG leads. Recently, new systems have been introduced for continuous on-line analysis of 12-leads or orthogonal vector lead ECGs, which have overcome the limitations of these earlier technologies' 8 " 121 . However, the additional value of 12-lead ECG analysis over 2 or 3 leads or single lead analysis in patients with unstable angina is not reported. Comparative studies of different lead systems have been performed to address the value of multilead exercise electrocardiography [13~l5] . These results, however, may not be applicable to patients with unstable angina, since the pathophysiology of unstable angina differs from the pathophysiology of stable angina (plaque rupture and coronary thrombosis vs fixed stenosis with ischaemia due to increased myocardial oxygen consumption).
The aim of the present study was to compare continuous 12-lead ST monitoring with more conventional 3-lead ST monitoring for detection and quantitation of ischaemia in patients with unstable angina, and to investigate which leads most frequently contribute to the detection of ST episodes. A new algorithm for detection and quantitation of ischaemic events is presented, which takes into account all 12 ECG leads simultaneously.
Methods

Study patients
One hundred and thirty patients, who were hospitalized for unstable angina and who participated in a dosefinding study of a new anti-thrombin agent, underwent continuous 12-lead ST monitoring in 18 hospitals (see appendix) 1 ' 6171 . Patients were eligible for the study if an episode of chest pain was accompanied by dynamic ST and/or T wave changes indicative of myocardial ischaemia. Patients with ECG abnormalities, such as left bundle branch block, left ventricular hypertrophy or artificial pacemaker device, making ST segment interpretation unreliable, were excluded, as were patients with a recent myocardial infarction.
Continuous ST monitoring
Continuous ECG monitoring was performed using the ELI-100 continuously updated 12-lead ECG monitoring system (Mortara Instruments, Milwaukee, U.S.A.), which automatically calculates median ECG complexes of the 12 ECG leads every 15 s. The system was programmed to store median ECG complexes every 20 s if > 100 uV ST segment shift was present in one lead relative to the baseline ECG of that patient, or if > 50 uV ST shift was present in any two leads of the 12-lead ECG. If little or no ST change was present, a baseline median ECG was stored every 20 min.
Median ECG complexes and ST trend data were stored on a removable hard disk or floppy disk. After completion of the recording, this disk was sent to the Cardialysis core laboratory (Rotterdam, The Netherlands) for subsequent editing and analysis.
Editing and analysis of recorded data
Before editing, the 12-lead ECG templates at the start of the continuous ECG recording were compared with the study entry 12-lead ECGs in order to verify proper lead placement. In the case of discordance, the recording was rejected.
All median QRST templates were manually scanned and edited for artifacts, intermittent bundle branch block, detection or marker errors and postural changes. The latter was defined as a sudden change of the frontal QRS axis and/or a sudden QRS amplitude change from V, to V 6 or vice versa. After editing, the trends of the ST segment level measured at the J-point+60ms were generated for each single lead of the 12-lead ECG, except aVR.
Reference ECG
At study entry, an attempt was made to document both a standard 12-lead ECG during chest pain and a 12-lead ECG without chest pain. These ECGs were used to define a reference 'non-ischaemic' (without chest pain) median ECG complex during the continuous ECG recording. If the median ECG complex at the start of the recording was similar to the study entry non-ischaemic 12-lead ECG, this ECG complex was used as the reference 'non-ischaemic' continuous ECG complex. If the first ECG complex was not similar to the study-entry non-ischaemic 12-lead ECG, attempts were made to identify the most comparable 'non-ischaemic' ECG complex of the continuous ECG recording. Subsequently, this ECG complex was used as the reference 'non-ischaemic' ECG.
Definition of ST episodes
The onset of an ST episode was defined as a change of ST-amplitude in one or more leads of at least ± 100 uV from the baseline ST level, developing within a 10 min period and persisting for at least 1 min. The end of an episode was defined as a return of the ST level within ± 100 uV of the baseline ST level, again lasting for at least 1 min. Episodes had to be separated from each other by at least 1 min. If >100uV ST change was present in more than one lead simultaneously, the episode onset was defined by the lead exhibiting the first significant ST change. Similarly, the end of an episode was defined by the lead exhibiting the latest return to baseline ST level. An example of the ST trend analysis and representative ECG recordings is presented in Figs 1 and 2.
Automated detection of ST segment changes >100\iV
An algorithm programmed according to the previously described ST criteria for ischaemia was applied to each single lead ST trend, in order to detect both the time and ST values of onset and offset of an ST episode and its peak ST level. In order to prevent a reversal of baseline with a real ST episode (or false detection of an untrue ST episode), the algorithm was programmed to skip episodes of which the onset ST value was closer to the initial reference ST level than the baseline ST level during the predefined 10 min window. In such an instance, the ST value was used as baseline update for the detection of a possible next episode. Subsequently, the digital trend analysis was confirmed by a second visual analysis of the real-time ECG, thus double checking template quality and excluding Eur Heart J. Vol. 18, June 1997 false-positive or false-negative automated ST measurements. The ECG at moments of interest, either detected by the algorithm or by the operator, was documented on hard copy for visual inspection (Fig. 2) .
ST episodes based on 12-lead and 3-lead ST trends
As a final summary analysis, the total number of ST episodes was calculated based on both the combination of either 3 leads HI, V 2 and V 5 or the combination of all 12 leads (except aVR).
Statistical analysis
Continuous variables are expressed as median and interquartile range (25th and 75th percentiles). Unpaired variables were compared using the Mann-Whitney test. Wilcoxon signed rank test was used for paired variables. were compared using the chi-square test. The number of episodes per patient during 3-lead and 12-lead ST monitoring might differ in two directions, since both more and less frequent ST episodes might be detected by 12 leads compared with 3 leads. The latter might be due to combining of multiple short episodes in one long episode. This would result in fewer episodes but a longer ischaemic duration. Therefore, a two-tailed P value was calculated in all instances. A P value of <005 was considered statistically significant. The Kaplan-Meier method was used for the evaluation of the time to the occurrence of a first ST episode and the possibility of a recurrent ST episode, with censoring of data. Statistical difference was tested with the Log rank test. ST episode (73%), against 46 (65%) of the 71 patients during 3-lead monitoring (/ > =002). Several other observations support the greater sensitivity for detection of ST segment changes of 12-lead monitoring over 3 leads. For example, the first ST episode during monitoring was detected earlier by 12 leads (Table 1 and Fig. 3) , and the duration of ischaemia detected by 12 leads exceeded the duration in 3 leads (Fig. 4) . Furthermore, the number of leads involved per ST episode was higher for 12-lead than for 3-lead ST monitoring (Table 2) .
Results
ECG
For 12-lead ST monitoring, episodes with precordial lead involvement only were far more frequently present than episodes with only standard or augmented lead involvement (77% against 11% respectively, P<0-0001). Simultaneous involvement of both the standard or augmented leads and the precordial leads was present in 60 out of 515 ST episodes (12%). A shift of ST episodes from either the standard or augmented leads to the precordial leads or vice versa occurred in 20 (31%) of the 64 patients who had more than one ST episode during 12-lead ST monitoring. For 3-lead ST monitoring, the single lead episodes of V 2 contributed most to the detection of the onset of ST episodes (Fig. 5, panel B, P<00001 ), while V 2 , V 3 and V 4 were equally sensitive in the 12-lead analysis (Fig. 5, panel A) . Figure 6 shows a Kaplan-Meier 'survival' analysis with censoring of data of the probability to remain free of a new ST episode during the course of the monitoring period using 12 leads. The probability of a recurrent ST episode declined most during the first 24 h of monitoring. There was no difference between the probability of occurrence of a new ST episode after the start of the ECG monitoring period or the probability of recurrence of a second ST episode after the first, or a third after the second episode.
Forty-five patients (39%) had at least one episode of chest pain during ECG monitoring. However, ST changes of > 100 uV were present during those episodes in 10 patients only (22%), during both 3-and 12-lead ECGs. If additional less prominent ST and T wave changes similar to the study entry ECG were also taken into account, ECG signs of ischaemia were present during chest pain in 26 patients (58%). There was no significant difference between the number of ST episodes in patients with and without episodes of chest pain.
Nineteen patients (17%) suffered from an inhospital cardiac event and/or underwent emergency angiography within the first 7 days of admittance to hospital. There were no cardiac deaths. Clinical events occurred more frequently in patients with chest pain during the monitoring period and in patients with chest pain and concomitant ST episodes compared to those without recurrent ischaemia (Table 3) . These observations were, however, not statistically significant in this small series of patients. In patients with an acute myocardial infarction receiving thrombolytic therapy, computer assisted continuous ECG monitoring has proven to be of clinical value for prediction of vessel status and identification of high risk patients' 10 " 121 . However, so far, no systematic studies have been conducted to evaluate the usefulness of computer-assisted continuous 12-lead ECG monitoring techniques in patients with unstable angina. To our knowledge, this study is the first to demonstrate the relationship between detection and quantitation of ischaemia and ECG monitoring technology in these patients. Twelve lead ST monitoring appeared to be more sensitive than the more generally applied 3-lead technology. When only three leads were used for ST monitoring, ischaemia was detected in 62% of patients, which is comparable to studies using Holter ST monitoring in patients with unstable angina' 1191 . With 12-lead ST monitoring, ischaemia was detected in an additional 15% of patients. Both the number and duration of ischaemic episodes far increased using 12-lead compared to 3-lead ST monitoring.
The ST changes were found to disperse and shift among different leads in time in at least 31% of patients with more than one ST episode during the monitoring period. This may depend on the flow balance of the coronary system, the degree of vessel injury and the duration and severity of ischaemia. Thus, instead of monitoring the lead with maximal ST deviation or sum ST deviation in patients with myocardial infarction' 202 ' 1 , full 12-lead ST monitoring should be preferred for detection and quantitation of ischaemia in patients with unstable angina. The major differences between ST monitoring of unstable angina patients vs ST monitoring of acute myocardial infarction patients are listed in Table 4 . ST episodes were most frequently present in the leads V 2 , V 3 and V 4 . In addition, these leads also contributed most to the detection of the onset of ST episodes if all involved leads were taken into account. This is in contrast to previous studies on body surface mapping and optimal lead placement during exercise electrocardiography in patients with coronary artery disease' 13 " 151 . These studies demonstrated that the single lead with the greatest sensitivity for detecting ST segment shift was between the right infraclavicular region area and the V 5 position, which is in fact a bipolar V 5 lead. Our data do not support these findings and suggest that studies on lead placement and ST shift during exercise testing in patients with stable angina may not be applicable to patients with unstable angina in whom both the underlying pathophysiological mechanism and the extent and area of ischaemia is different' 22 '. In addition, our results indicate that ST episodes with only standard lead involvement are rare. As such, it is conceivable that the applied cut-off value of >100uV ST change is not adequate for standard lead monitoring in general practice.
Previous studies on patients with unstable angina demonstrated that recurrent ischaemia occurs most frequently in the first 24-48 h of admission to hospital' 22 ' 231 . This is in concordance with our finding that the majority of patients exhibited a recurrence of ischaemia within the first 15 h of ST monitoring, with only 23% of patients remaining free of an ST episode during the total monitoring period (Fig. 3) . In addition, Fig. 6 demonstrates that the distribution of the occurrence of an ST episode over time was similar for the first interval since the start of the ST monitoring period, as well as for the occurrence of a second episode after the first and a third after the second. This suggests similar underlying pathophysiological mechanisms of these episodes' 231 . Apparently, plaques stabilize and become quiescent' after a period without recurrent ischaemia of approximately 24 h.
In agreement with Holter ST studies in patients with unstable angina, ST changes of >100|iV during moments of chest pain were infrequently present, occurring in only 22% of the patients with chest pain during the monitoring period' 19 ' 24 ' 25 '. This may be due to at least three factors: (1) complaints may not always be of ischaemic origin, (2) generally accepted > 100 uV ST change criterion for detection of ischaemia may be too insensitive to pick up minor ischaemic ECG changes that may occur in these unstable patients. The latter assumption is supported by the fact that minor ST and T wave changes, similar to the study entry ECG during pain were present during pain in 58% of all patients who had episodes of chest pain during the recording. This implies that not only ST changes of >100uV but also smaller ST and T wave changes should be taken into account as signs of ischaemia in these patients. Until recently, the standardization and automated detection and quantitation of these minor ST and T wave changes was hampered by the limitations of earlier ECG technologies such as Hotter, because of baseline drift and restriction of number of leads. In contrast, the high quality ECG signals provided by computer-assisted ECG monitoring technologies have overcome these limitations and may challenge us to develop new ischaemia standards and algorithms for automated detection and quantitation.
Finally, in contrast to other studies using Holter ST recording techniques' 1 ' 19 ' , we did not demonstrate a significant difference in the occurrence of in-hospital cardiac events within the first week from admittance between patients with and without ST episodes, although trends were similar to previous studies (Table 3) . This may be due to the small number of patients who suffered from an in-hospital clinical event. We conclude that computer-assisted 12-lead ECG monitoring can be used for on-line ECG ischaemia monitoring of unstable angina patients both for clinical purposes and for quantitation of myocardial ischaemia in studies. The use of continuous 12-lead ST monitoring significantly increased the detection rate of ST episodes as compared to more conventional continuous 3-lead ST monitoring. Furthermore 12-lead ST monitoring yields more episodes and longer duration of ischaemia. Whether this also relates to a better specificity for prediction of impending clinical events could not be established from the small subset of patients who actually suffered an in-hospital clinical event during this study. Computer-assisted 12-lead ECG monitoring systems are recommended on emergency wards and coronary care units, not only for monitoring of patients with an acute myocardial infarction receiving thrombolytic therapy, but also for monitoring of unstable angina patients.
